3.9750
+0.0250
+(0.63%)
As of 2:13:29 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.1 | -0.02 | 0.27 | 1.13 |
| Low Estimate | -0.1 | -0.02 | 0.27 | 1.13 |
| High Estimate | -0.1 | -0.02 | 0.27 | 1.13 |
| Year Ago EPS | -- | -- | -- | 0.27 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | 7.28M | 72.83M | 185.71M |
| Low Estimate | -- | 7.28M | 72.83M | 185.71M |
| High Estimate | -- | 7.28M | 72.83M | 185.71M |
| Year Ago Sales | -- | 41k | 41k | 72.83M |
| Sales Growth (year/est) | 0.00% | 17,663.41% | 177,529.26% | 155.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.27 | -0.31 | -0.15 | -0.19 |
| EPS Actual | -0.33 | -0.18 | -0.23 | -0.69 |
| Difference | -0.06 | 0.13 | -0.08 | -0.5 |
| Surprise % | -20.73% | 40.98% | -56.81% | -263.16% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.02 | 0.27 | 1.13 |
| 7 Days Ago | -0.1 | -0.02 | 0.27 | 0.92 |
| 30 Days Ago | -0.1 | -0.02 | 0.27 | 0.92 |
| 60 Days Ago | -0.1 | -0.02 | 0.27 | 0.92 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CKPT | -- | -- | -- | 318.52% |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 3/31/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 3/11/2025 |
| Downgrade | Lake Street: Buy to Hold | 3/10/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/10/2025 |
| Initiated | D. Boral Capital: Buy | 1/13/2025 |
| Maintains | Lake Street: Buy to Buy | 12/16/2024 |
Related Tickers
FBIO Fortress Biotech, Inc.
1.4600
+2.11%
MBIO Mustang Bio, Inc.
1.3309
+4.80%
TGTX TG Therapeutics, Inc.
36.28
+2.10%
GLMD Galmed Pharmaceuticals Ltd.
1.4700
+13.08%
ABEO Abeona Therapeutics Inc.
4.3700
+1.16%
CHRS Coherus BioSciences, Inc.
0.8448
+9.53%
MIST Milestone Pharmaceuticals Inc.
0.7095
+8.67%
ITRM Iterum Therapeutics plc
1.1400
+2.70%
MREO Mereo BioPharma Group plc
1.8700
+6.25%
CLRB Cellectar Biosciences, Inc.
0.2535
+5.36%